The primary goal was to establish acceptable analytical targets by examining human hepatocyte incubation samples with substantial-resolution mass spectrometry (HRMS) and to verify the effects in genuine urine specimens and to find out AB-FUBINACA's metabolic balance in human liver microsomes and in comparison hepatocyte and urine benefits with in s